XNASMEDS
Market cap13mUSD
Sep 20, Last price
7.59USD
Name
TRxADE Health Inc
Chart & Performance
Profile
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 8,272 -27.74% | 11,448 15.76% | 9,889 -42.24% | |||||||
Cost of revenue | 15,536 | 14,205 | 15,323 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (7,263) | (2,757) | (5,434) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 5,336 | 400 | (1,203) | |||||||
Tax Rate | ||||||||||
NOPAT | (12,599) | (3,157) | (4,231) | |||||||
Net income | (17,844) 313.98% | (4,310) 4.79% | (4,113) 60.33% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 518 | 131 | 17 | |||||||
BB yield | -4.19% | -57.56% | -1.31% | |||||||
Debt | ||||||||||
Debt current | 6,809 | 364 | 179 | |||||||
Long-term debt | 1,392 | 2,304 | 2,318 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | (409) | |||||||||
Net debt | 8,050 | 1,534 | (626) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (2,074) | (1,526) | (2,566) | |||||||
CAPEX | (451) | (23) | ||||||||
Cash from investing activities | (276) | (428) | (23) | |||||||
Cash from financing activities | 1,406 | (35) | (208) | |||||||
FCF | (9,474) | (2,438) | (2,702) | |||||||
Balance | ||||||||||
Cash | 152 | 1,134 | 3,123 | |||||||
Long term investments | ||||||||||
Excess cash | 561 | 2,628 | ||||||||
Stockholders' equity | (33,246) | (20,140) | (16,247) | |||||||
Invested Capital | 40,211 | 22,066 | 21,266 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 2,381 | 565 | 542 | |||||||
Price | 5.20 1,190.69% | 0.40 -82.94% | 2.36 -55.47% | |||||||
Market cap | 12,375 5,341.49% | 227 -82.24% | 1,280 -52.98% | |||||||
EV | 20,425 | 1,341 | 655 | |||||||
EBITDA | (6,214) | (2,561) | (5,295) | |||||||
EV/EBITDA | ||||||||||
Interest | 1,198 | 336 | 24 | |||||||
Interest/NOPBT |